EGFR point mutation confers resistance to gefitinib in a patient with non-small-cell lung cancer.
Giaccone
Giuseppe
G
Department of Medical Oncology, Free University Medical Center, Amsterdam, The Netherlands. g.giaccone@vumc.nl